Barrett's oesophagus: Intestinal metaplasia is not essential for cancer risk

Scandinavian Journal of Gastroenterology

Volumn 42, Issue 11, 2007, Pages 1271-1274

  Kelty, Clive J ^a,b   Gough, Martin D ^a   Van Wyk, Quintin ^a   Stephenson, Timothy J ^a   Ackroyd, Roger ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Adenocarcinoma; Barrett's oesophagus; Cancer risk

Indexed keywords

ARTICLE; BARRETT ESOPHAGUS; CANCER RISK; CARCINOGENESIS; COLUMNAR EPITHELIUM; CONTROLLED STUDY; ENDOSCOPIC BIOPSY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS BIOPSY; ESOPHAGUS MUCOSA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT;

ADENOCARCINOMA; BARRETT ESOPHAGUS; BIOPSY; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; HUMANS; INCIDENCE; MALE; METAPLASIA; MUCOUS MEMBRANE; RISK FACTORS;

EID: 35148884884     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520701420735     Document Type: Article

References (32)

1. Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol 1994;25:982-93.
2. Falk GW. Reflux disease and Barrett's esophagus. Endoscopy 1999;31:9-16.
3. Gillen P, Keeling P, Byrne PJ, Healy M, O'Moore RR, Hennsey TP. Implication of duodenogastric reflux in the pathogenesis of Barrett's oesophagus. Br J Surg 1988;75: 540-3.
4. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985;313:857-9.
5. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049-53.
6. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993;104:510-3.
7. Blot WJ, McLaughlin JK. The changing epidemiology of esophageal cancer. Sem Oncol 1999;26:2-8.
8. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005;97:142-6.
9. Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002;97:1888-95.
10. Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 1997; 92:212-5.
11. Spechler SJ, Robbins AH, Rubins HB, Vincent ME, Heeren T, Doos WG, et al. Adenocarcinoma and Barrett's esophagus. An overrated risk? Gastroenterology 1984;87:927-33.
12. Hameeteman W, Tytgat GN, Houthoff HJ, van den Tweel JG. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989;96:1249-56.
13. Streitz JM Jr, Williamson WA, Ellis FH Jr. Current concepts concerning the nature and treatment of Barrett's esophagus and its complications. Ann Thorac Surg 1992;54:586-91.
14. Wright TA, Gray MR, Morris AI, Gilmore IT, Ellis A, Smart HL, et al. Cost effectiveness of detecting Barrett's cancer. Gut 1996;39:574-9.
15. Williamson WA, Ellis FH Jr, Gibb SP, Shahian DM, Aretz HT, Heatley GJ, et al. Barrett's esophagus. Prevalence and incidence of adenocarcinoma. Arch Int Med 1991;151: 2212-6.
16. Macdonald CE, Wicks AC, Playford RJ. Final results from a 10-year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study. Br Med J 2000; 321:1252-5.
17. O'Connor JB, Falk GW, Richter JE. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol 1999;94:2037-42.
18. Murray L, Watson P, Johnston B, Sloan J, Mainie IM, Gavin A. Risk of adenocarcinoma in Barrett's oesophagus: population based study. Br Med J 2003;327:534-5.
19. Ronkainen J, Aro P, Storskrubb T, Joahansson SE, Lind T, Bolling-Sternevald E, et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 2005;129:1825-31.
20. Winters C Jr, Spurling TJ, Chobanian SJ, Curtis DJ, Esposito RL, Hacker JF III, et al. Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 1987;92:118-24.
21. Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS. Is there publication bias in the reporting of the cancer risk for Barrett's esophagus? Gastroenterology 2000;119:333-8.
22. Paull A, Trier JS, Dalton MD, Camp RC, Loeb P, Goyal RK. The histologic spectrum of Barrett's esophagus. N Engl J Med 1976;295:476-80.
23. Hellier MD, Shepherd NA. Diagnosis of columnar-lined oesophagus. In: Watson A, Heading RC, Shepherd NA, editors. Guidelines for the diagnosis and management of Barrett's columnar-lined oesophagus report of the Working Party of the British Society of Gastroenterology. Br Med J Publ 2005;28:13-7.
24. Chandrasoma PT, Der R, Dalton P, Koyabashi G, Ma Y, Peters J, et al. Distribution and significance of epithelial types in columnar-lined esophagus. Am J Surg Pathol 2001; 25:1188-93.
25. Gore S, Healey CJ, Sutton R, Eyre-Brook IA, Gear MW, Shepherd NA, et al. Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy. Aliment Pharmacol Ther 1993;7:623-8.
26. Heitmiller RF, Redmond M, Hamilton SR. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg 1996;224:66-71.
27. Incarbone R, Bonavina L, Saino G, Bona D, Peracchia A. Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus. Surg Endosc 2002;16:263-6.
28. Zaninotto G, Parenti AR, Ruol A, Costantini M, Merigliano S, Ancona E. Oesophageal resection for high-grade dysplasia in Barrett's oesophagus. Br J Surg 2000;87:1102-5.
29. Chang LC, Oelschlager BK, Quiroga E, Parra JD, Mulligan M, Wood DE, et al. Long-term outcome of esophagectomy for high-grade dysplasia or cancer found during surveillance for Barrett's esophagus. J Gastrointest Surg 2006;10:341-6.
30. Gladman L, Chapman W, Iqbal TH, Gearty JC, Cooper BT. Barrett's oesophagus: an audit of surveillance over a 17-year period. Eur J Gastroenterol Hepatol 2006;18:271-6.
31. Harrison R, Perry I, Haddadin W, Mcdonald S, Bryan R, Abrams K, et al. Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies. Am J Gastroenterol 2007;102:1-8.
32. Ishaq S, Harper E, Brown J, Moayyedi P, Wicks T, Watson P, et al. Survey of current clinical practice in the diagnosis, management and surveillance of Barrett's metaplasia: a UK national survey. Gut 2003;52:A32.